GSK's Q-Pan H5N1 Vaccine Receives FDA Nod

by Kathy Jones on  December 2, 2013 at 9:31 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration has finally approved GlaxoSmithKline's Q-Pan H5N1 vaccine for treating H5N1 avian flu.
 GSK's Q-Pan H5N1 Vaccine Receives FDA Nod
GSK's Q-Pan H5N1 Vaccine Receives FDA Nod

The vaccine had received a unanimous nod from the FDA's vaccine advisory board but the agency revealed it will not be approving the vaccine at that time after GSK reported a technical hitch.

The FDA revealed that the vaccine is the first to make use of an adjuvant and added that it will not be available for commercial use but will be stockpiled in case of a human H5N1 flu pandemic.

"This vaccine could be used in the event that the H5N1 avian influenza virus develops the capability to spread efficiently from human to human. Vaccines are critical to protecting public health by helping to counter the transmission of influenza disease during a pandemic", Karen Midthun, the director of FDA's Center for Biologics Evaluation and Research, said.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Bird Flu Vaccination for Children Top 10 Vaccine Myths Debunked 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive